Bioceres Crop Solutions Corp. (BIOX) News
Follow Bioceres Crop Solutions Corp. (BIOX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 13 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BIOX: Revenue fell 18% amid restructuring, but cost cuts drove EBITDA improvement and margin targets
Fiscal 2026 saw an 18% revenue decline due to litigation and business restructuring, but cost reductions led to improved adjusted EBITDA and stabilization in core segments. The company targets 40% gross margins and furth
EARNINGS | Sep 15, 2026, 01:26 PM UTC
L
BIOX: Revenue declined 18% amid restructuring, but cost actions drove Q4 EBITDA back to positive
Fiscal 2026 saw an 18% revenue decline due to litigation and business restructuring, but Q4 showed stabilization with cost reductions and a return to positive adjusted EBITDA. The company targets 40% gross margins and fu
EARNINGS | Sep 15, 2026, 01:10 PM UTC
L
BIOX: Stable 4Q26 revenues and cost cuts improved EBITDA, but FY26 saw lower sales and ongoing legal risks
Revenues were stable in 4Q26 but declined 18% for FY26, mainly due to Seeds business reconfiguration and lower HB4 activities. Cost reductions improved Adjusted EBITDA and narrowed net losses, while ongoing legal dispute
EARNINGS | Sep 15, 2026, 10:39 AM UTC
L
BIOX: Stable 4Q26 revenues and improved cost controls offset ongoing net losses and portfolio transitions
Revenues remained stable in 4Q26, with strong Crop Nutrition growth offsetting declines elsewhere, while FY26 revenues fell 18% year-over-year. Cost actions improved SG&A and Adjusted EBITDA, but net losses persisted. Fo
EARNINGS | Sep 14, 2026, 11:22 PM UTC
L
Argentina's Bioceres Q4 revenue nearly flat, gross profit falls
OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact re
EARNINGS | Sep 14, 2026, 10:56 PM UTC
L
BIOX - Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results
BIOX - Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results
NEWS | Sep 14, 2026, 10:54 PM UTC
L
Bioceres Crop Solutions 4Q Rev $55.9M >BIOX
Bioceres Crop Solutions 4Q Rev $55.9M >BIOX
NEWS | Sep 14, 2026, 10:50 PM UTC
L
Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results
Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to cli
EARNINGS | Sep 14, 2026, 10:44 PM UTC
M
Bioceres Crop Solutions to report Q4'26 results Sep. 14
BIOX is scheduled to announce Q4'26 results on September 14 at 8:00 AM ET, with estimates of revenue at 79.00 million USD and EPS of (0.06) USD.
EQUITY | Sep 11, 2026, 11:00 AM UTC
L
Bioceres Crop Solutions to host FY2026 results call Sept 15
EARNINGS | Sep 09, 2026, 10:00 PM UTC
L
Bioceres to host 2026 results call on Sept. 15 at 8:30 a.m. ET
EQUITY | Sep 09, 2026, 09:59 PM UTC
L
BIOX set to report Q4'26 results; EPS seen at $(0.06)
BIOX is set to announce Q4'26 results on September 03, with disclosure expected at 8:00 AM ET. Q4'26 revenue is estimated at 79.00 million USD and EPS anticipated at $(0.06).
EARNINGS | Sep 02, 2026, 11:00 AM UTC
L
BIOX Q4'26 revenue estimate 79.00M USD
BIOX’s Q4'26 revenue estimate is 79.00M USD.
EARNINGS | Aug 27, 2026, 11:00 AM UTC